We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Meldex | LSE:MDX | London | Ordinary Share | GB0032681628 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.09 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Medisico plc - Allotment of new shares 10 October 2014 Medisico plc ("Medisico" or "the Company") Issue of new shares The Directors of Medisico plc are pleased to announce that the 2,300,000 new ordinary shares of nominal value £0.001 were allotted by way of a board resolution dated 1 October 2014. Details of securities issued: Sl.No. Date of allotment No. of shares Consideration 1. 01-10-2014 50,000 £0.10 2. 01-10-2014 2,000,000 £0.01 3. 01-10-2014 250,000 £0.01 Total 2,300,000 Of the above allotted securities, 2,000,000 shares have been allotted to Alexandra Louise Fullwood and 250,000 shares to Morgan Ann Clond on their appointment as directors for the subsidiary companies, Medisico Aesthetic Medicine Ltd and Medisico Academy Ltd respectively. Total paid up issued share capital after the above issue of shares is £150,750 divided into 150,750,000 Ordinary shares of £0.001 each. The directors of Medisico accept responsibility for this announcement. Disclaimer This Document includes "forward-looking statements." All statements other than statements of historical fact within this Document, including statements regarding Medisico plc, plans, objectives and expectations, are all forward-looking statements. Although Medisico plc believes that the expectations reflected in such forward-looking statements are reasonable at this time, it can give no assurance that such expectations will prove to have been correct. There will always be factors beyond the Company's control that may cause actual results to differ materially from expectations. As such subsequent written and oral forward-looking statements attributable to Medisico plc or persons acting on its behalf are expressly qualified in this regard.
Copyright r 10 PR Newswire
1 Year Meldex Chart |
1 Month Meldex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions